TherapeuticsMD (TXMD) just reported a mixed Q2 earnings with a $0.06 miss on EPS and a $0.96M beat on revenue. TXMD reported net revenue of $6.08M, which was a 61.7% increase year-over-year and was above the company's guidance of $4.5-5.5M. IMVEXXY's net revenue was up 55% compared to Q1 coming in around $3.12M, which was above the company's guidance of $2.5-3M. TXMD launched BIJUVA on April 17th and recorded approximately $134K in BIJUVA net revenue for the partial quarter. Surprisingly, the company's prenatal vitamins segment recorded ~$2.8M in net revenue which was also